English Journal

Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine.

Freitag FG1, Cady R, DiSerio F, Elkind A, Gallagher RM, Goldstein J, Klapper JA, Rapoport AM, Sadowsky C, Saper JR, Smith TR.
Headache.Headache.2001 Apr;41(4):391-8.
OBJECTIVE: To compare the safety and efficacy of isometheptene mucate, dichloralphenazone with acetaminophen to sumatriptan succinate for the treatment of mild-to-moderate migraine, with or without aura, when taken at the first sign of an attack.BACKGROUND: The Food and Drug Administration approved
PMID 11318886

Raskin NH1, Baringer JR.
Hospital practice (1995).Hosp Pract (1995).1996 Feb 15;31(2):93-6, 101-4.
Women with migraine often experience a worsening of symptoms at menopause. Use of exogenous estrogens is not helpful and may even exacerbate the condition. Although initial pharmacologic management generally is focused on control of individual headaches, attempts to stabilize the underlying migraine
PMID 8592022